Use of combined Oral Contraceptives accounts for an increase in risk of -

OCP provide protection against ovarian and endometrial cancer. OCP do not increase the risk (incidence) of breast cancer, but may increase the progression of breast cancers once they have occurred. Use of OCP in breast cancer patients is contraindicated.